A. The criteria are met for major or mild neurocognitive disorder.
B. The neurocognitive impairments do not occur exclusively during the course of a delir- ium and persist beyond the usual duration of intoxication and acute withdrawal.
C. The involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment.
D. The temporal course of the neurocognitive deficits is consistent with the timing of sub- stance or medication use and abstinence (e.g., the deficits remain stable or improve after a period of abstinence).
E. The neurocognitive disorder is not attributable to another medical condition or is not better explained by another mental disorder.
Coding note: The lCD-9-CM and lCD-10-CM codes for the [specific substance/medica- tion]-induced neurocognitive disorders are indicated in the table below. Note that the ICD- 10-CM code depends on whether or not there is a comorbid substance use disorder present for the same class of substance. If a mild substance use disorder is comorbid with the sub- stance-induced neurocognitive disorder, the 4th position character is "1," and the clinician should record “mild [substance] use disorder” before the substance-induced neurocognitive disorder (e.g., “mild inhalant use disorder with inhalant-induced major neurocognitive disor- der"). If a moderate or severe substance use disorder is comorbid with the substance- induced neurocognitive disorder. the 4th position character is “2" and the clinician should record “moderate [substance] use disordel” or “severe [substance] use disorder,” depending on the severity of the comorbid substance use disorder. If there is no comorbid substance use disorder, then the 4th position character is “9" and the clinician should record only the substance-induced neurocognitive disorder. For some classes of substances (i.e., alcohol; sedatives, hypnotics, anxiolytics), it is not permissible to code a comorbid mild substance use disorder with a substance-induced neurocognitive disorder; only a comorbid moderate or severe substance use disorder, or no substance use disorder, can be diagnosed. Behav- ioral disturbance cannot be coded but should still be indicated in writing.
With use disorder, disorder, moderateor Without use
Alcohol (major neurocognitive 291.2 NA F1027 F1097 disorder), nonamnestic-
Alcohol (major neurocognitive 291.1 NA F1026 F1096 disorder), amnestic-
Alcohol (mild neurocognitive 291.89 NA F10.288 F10.988
Inhalant (major neurocognitive 292.82 F1817 F1827 F1897
Inhalant (mild neurocognitive 292.89 F18.1BB F18.288 F18.988
Sedative, hypnotic, or anxiolytic 292.82 NA F1327 F1397
Sedative, hypnotic, or anxiolytic 292.89 NA F13.288 F13.988
Other (or unknown) substance 292.82 F1917 F1927 F1997
Other (or unknown) substance 292.89 F19.188 F19.288 F19.988
Specify if:
PersistentaNeurocognitive impairment continues to be significant after an extended period of abstinence.